Insider trade

Officer sold ~$4.43M of UTHR shares in the open market

Traded Feb 23, 2026 · Filed Feb 25, 2026

Why it stands out

United Therapeutics's PRESIDENT AND COO sold $4.43M of United Therapeutics shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

OfficerIndirect holding$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$4,426,181

Shares × reported transaction price

Timing vs results

117 days after results of Oct 29, 2025, 2 days before results of Feb 25, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−8.4%	−1.2%	−7.2%
30 days	−2.3%	−8.5%	+6.2%
90 days	+8.1%	+8.3%	−0.2%
180 days	−4.2%	+10.1%	−14.3%

Past results only. Not a forecast.

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan.
Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.

Filed 6mo ago

Traded Mar 25 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

Scheduled in advanceFiled 6mo ago

Scheduled in advanceFiled 6mo ago